Keywords: immunex, leukine, gains, fda, approval, aml, corp

Immunex' Leukine Gains FDA Approval For AML

Article | 25 September 1995

Print This

Immunex Corp has been granted approval by the Food and Drug Administration to market its Leukine (sargramostim), a yeast-derived GM-CSF, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in